History
  • No items yet
midpage
In Re: Affinity Labs of Texas, LLC
856 F.3d 883
| Fed. Cir. | 2017
Read the full case

Background

  • Affinity Labs owns U.S. Patent No. 7,324,833, directed to displaying and controlling audio files of a portable media player on a different electronic device (e.g., car audio) via a graphical user interface and soft buttons.
  • Three reexamination requests were granted: King (ex parte), Volkswagen (inter partes), and Apple (inter partes); the PTO sua sponte merged the three reexaminations and later severed Volkswagen’s proceeding as to claims litigated in district court.
  • Volkswagen litigated claims 28 and 35 in district court and lost its invalidity challenge; Apple settled and exited reexamination; King remained as an ex parte requester.
  • Affinity petitioned under pre‑AIA 35 U.S.C. § 317(b) to terminate the merged reexamination entirely, arguing estoppel based on Volkswagen’s adverse final judgment; PTO denied termination except as to claims 28 and 35 in the severed Volkswagen reexamination.
  • Examiners rejected numerous claims; the PTAB affirmed rejections in two decisions (the court affirms the -4281 Board Decision upholding unpatentability of claims 1–27, 37–42, 45–46 and remands only to correct record that claim 36 is rejected).

Issues

Issue Affinity's Argument PTO/Intervenor's Argument Held
Scope of §317(b) estoppel—must the PTO terminate all merged reexaminations when a requester loses in district court? §317(b) requires termination of the pending inter partes reexamination(s) in which the losing requester participated; merging shouldn’t expand estoppel to claims not litigated. §317(b) estoppel is claim‑based and applies only to claims actually decided against the requester; PTO followed MPEP practice in severing and limiting estoppel to litigated claims. Court: §317(b) plain text limits estoppel to the specific claims decided against the requester; PTO denial of full termination affirmed.
Whether §317(b) estoppel applies to ex parte reexamination or to non‑party requesters (Apple) Estoppel should bar challenges across merged proceedings, including ex parte and other inter partes requests tied to the same patent. §317(b) by its terms applies only to inter partes reexamination requesters who were parties (or privies) in the civil action; it does not reach ex parte proceedings or unrelated requesters. Court: §317(b) does not reach ex parte reexaminations and does not apply to Apple (not a party/privy); no termination required.
Anticipation by Dwyer of claims 1–27, 39, 45 (graphical item with name; preprogrammed soft buttons) Dwyer does not disclose a portable device displaying a named graphical interface item or preprogrammed soft buttons linked to audio sources as claimed. Dwyer discloses header/title data uploaded from recorder to PC, touch‑screen navigation, icons/fields acting as selectable buttons tied to stored audio—thus anticipates claimed elements. Court: Substantial evidence supports PTAB that Dwyer discloses the limitations; anticipation/obviousness upheld.
Obviousness over Naim + Lee (communication of name; physical mounting interface) and weight of objective indicia Naim and Lee do not disclose communicating a name field to another device or a physical mounting interface (Lee allegedly only wireless); Affinity’s commercial success and licensing show nonobviousness. Naim contemplates upload of recorded files (with identifying info) to a PC; Lee teaches a car multimedia device with soft buttons and a physical/wire interface can be wireless under broadest reasonable construction; commercial evidence lacks nexus/specificity. Court: Substantial evidence supports PTAB’s obviousness finding; claim constructions and nexus analysis proper; objective indicia afforded little weight.

Key Cases Cited

  • Pride Mobility Prods. Corp. v. Permobil, Inc., 818 F.3d 1307 (Fed. Cir.) (standard of review for PTO decisions under APA)
  • In re Gartside, 203 F.3d 1305 (Fed. Cir. 2000) (agency legal conclusions de novo, facts for substantial‑evidence review)
  • KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398 (2007) (law of obviousness and rationale for combining prior art)
  • King Pharm., Inc. v. Eon Labs, Inc., 616 F.3d 1267 (Fed. Cir.) (anticipation requires every claim limitation in a single reference)
  • In re Rambus, Inc., 753 F.3d 1253 (Fed. Cir. 2014) (broadest reasonable interpretation during reexamination)
  • Ormco Corp. v. Align Tech., Inc., 463 F.3d 1299 (Fed. Cir.) (nexus requirement for commercial success evidence)
  • Iron Grip Barbell Co. v. USA Sports, Inc., 392 F.3d 1317 (Fed. Cir.) (licenses require proof they reflect value of the patent, not litigation avoidance)
Read the full case

Case Details

Case Name: In Re: Affinity Labs of Texas, LLC
Court Name: Court of Appeals for the Federal Circuit
Date Published: May 5, 2017
Citation: 856 F.3d 883
Docket Number: 2016-1092, 2016-1172
Court Abbreviation: Fed. Cir.